As expected, the expression levels of many lipid-metabolic genes were altered in AOM-treated Pla2g3−/− mice compared with Pla2g3+/+ mice (Supplementary Table 1), likely as a result of the marked attenuation of colon cancer in the null mice. This evidence concerns the gene PLA2G3 and malignant colon neoplasm.